115 related articles for article (PubMed ID: 22456515)
1. Neurofibroma-like spindle cell melanoma: CD34 fingerprint and CGH for diagnosis.
Yeh I; Vemula SS; Mirza SA; McCalmont TH
Am J Dermatopathol; 2012 Aug; 34(6):668-70. PubMed ID: 22456515
[TBL] [Abstract][Full Text] [Related]
2. Neurofibroma with numerous lymphoid aggregates simulating spindle cell melanoma: utilization of CD34 fingerprint for diagnosis.
Hogan SR; Speiser JJ; Lee JM; Hutchens KA
Am J Dermatopathol; 2013 Dec; 35(8):870-1. PubMed ID: 23812017
[No Abstract] [Full Text] [Related]
3. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint.
Yeh I; McCalmont TH
J Cutan Pathol; 2011 Aug; 38(8):625-30. PubMed ID: 21457155
[TBL] [Abstract][Full Text] [Related]
4. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
5. Fingerprint CD34 immunopositivity to distinguish neurofibroma from an early/paucicellular desmoplastic melanoma can be misleading.
Husain S; Silvers DN
J Cutan Pathol; 2013 Nov; 40(11):985-7. PubMed ID: 24033860
[No Abstract] [Full Text] [Related]
6. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
7. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
[TBL] [Abstract][Full Text] [Related]
8. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
9. Differential diagnosis of melanocytic lesions and molecular biology.
Dummer R; Kerl K; Mihic D; Kamarachev J
Arch Dermatol; 2011 Feb; 147(2):232-3. PubMed ID: 21339451
[No Abstract] [Full Text] [Related]
10. Metastatic Melanoma to a Neurofibroma.
Ireland A; Williams B; Rijhumal A; Mesbah Ardakani N
Am J Dermatopathol; 2022 Sep; 44(9):683-686. PubMed ID: 35475788
[TBL] [Abstract][Full Text] [Related]
11. CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype.
Breza TS; Magro CM
J Cutan Pathol; 2005 Nov; 32(10):685-9. PubMed ID: 16293181
[TBL] [Abstract][Full Text] [Related]
12. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
14. A rare case of neurofibroma with lipomatous differentiation and floret like giant cells-cytologically disguising as pleomorphic lipoma.
Gaurish SK; Bhatt NC; Joshi A
Indian J Pathol Microbiol; 2014; 57(2):342-4. PubMed ID: 24943788
[No Abstract] [Full Text] [Related]
15. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
16. Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation.
Navarini AA; Bauer J; Barysch MJ; Kempf W; Mihic-Probst D; Kerl K; Kamarashev J; Giovanoli P; Kolios AG; Bergstraesser E; Dummer R
Eur J Dermatol; 2011; 21(2):229-33. PubMed ID: 21489908
[TBL] [Abstract][Full Text] [Related]
17. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
18. Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool.
Takata M; Maruo K; Kageshita T; Ikeda S; Ono T; Shirasaki F; Takehara K; Bastian BC
Hum Pathol; 2003 Jan; 34(1):89-92. PubMed ID: 12605371
[TBL] [Abstract][Full Text] [Related]
19. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
[TBL] [Abstract][Full Text] [Related]
20. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
